|
advertisement
|
|
|
| Journal Articles Details
|
|
More October, 2004 pharmacogenomics journal articles.- How molecular medicine transforms policy (and everything else).
by Kean MA, Batchelder KF.
Journal: J Biolaw Bus. 7(3):16-9
- Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.
by Clark JJ, Cools J, Curley DP, Yu JC, Lokker NA, Giese NA, Gilliland DG.
Journal: Blood. 104(9):2867-72
- Genetic testing in primary care.
by Burke W.
Journal: Annu Rev Genomics Hum Genet. 5:1-14
- Targeted therapies for cancer 2004.
by Ross JS, Schenkein DP, Pietrusko R, Rolfe M, Linette GP, Stec J, Stagliano NE, Ginsburg GS, Symmans WF, Pusztai L, Hortobagyi GN.
Journal: Am J Clin Pathol. 122(4):598-609
- Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
by Dimitrova A, Milanova V, Krastev S, Nikolov I, Toncheva D, Owen MJ, Kirov G.
Journal: Pharmacogenomics J. 10 2004;:
- Microarrays in pharmacogenomics.
by Chen JJ.
Journal: J Biopharm Stat. 14(3):535-7
- Pharmacogenomics and drug response in cardiovascular disorders.
by Siest G, Jeannesson E, Berrahmoune H, Maumus S, Marteau JB, Mohr S, Visvikis S.
Journal: Pharmacogenomics. 5(7):779-802
- Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
by Redon J, Luque-Otero M, Martell N, Chaves FJ.
Journal: Pharmacogenomics J. 10 2004;:
- Toward the pharmacogenomics of cystic fibrosis - an update.
by Sangiuolo F, D'Apice MR, Gambardella S, Di Daniele N, Novelli G.
Journal: Pharmacogenomics. 5(7):861-78
- Pharmacogenetics of irinotecan toxicity.
by Marsh S, McLeod HL.
Journal: Pharmacogenomics. 5(7):835-43
- [Adjuvant therapy for colon cancer]
by Lordick F, Rosenberg R, Stein HJ, Peschel C, Siewert JR.
Journal: Dtsch Med Wochenschr. 129(44):2366-71
- Pharmacogenomics of adrenoceptors.
by Flordellis C, Paris H, Karabinis A, Lymperopoulos A.
Journal: Pharmacogenomics. 5(7):803-17
- Genetic approaches to solving common diseases.
by Abou-Sleiman PM, Healy DG, Wood NW.
Journal: J Neurol. 251(10):1169-72
- Optimized antiretroviral therapy: the role of therapeutic drug monitoring and pharmacogenomics.
by van Heeswijk RP.
Journal: Expert Rev Anti Infect Ther. 1(1):75-81
- The wild genetic goose chase: Neil Holtzman talks about genetics and medicine [interview by Brandon Keim].
by Holtzman N.
Journal: Genewatch. 2004 Jul-Aug;17(4):6-10
- Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
by Serretti A, Zanardi R, Franchini L, Artioli P, Dotoli D, Pirovano A, Smeraldi E.
Journal: Pharmacogenetics. 14(9):607-13
- Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
by Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T.
Journal: Pharmacogenomics J. 10 2004;:
- Pharmacogenomics and colorectal cancer.
by
Journal: Ann Oncol. 15(suppl_4):iv173-iv177
- Clinical and functional consequences of platelet membrane glycoprotein polymorphisms.
by Yee DL, Bray PF.
Journal: Semin Thromb Hemost. 30(5):591-600
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|